Kucuk, LeventKececi, BurcinSabah, DundarYuceturk, Guven2019-10-272019-10-2720141017-995Xhttps://doi.org/10.3944/AOTT.2014.3171https://hdl.handle.net/11454/48656Objective: The aim of this study was to evaluate the results of surgical treatment of aggressive fibromatosis and the effects of prognostic factors on recurrence. Methods: Forty patients (24 female, 16 male; average age: 31.2 years) diagnosed with aggressive fibromatosis were evaluated retrospectively. Nine patients with tumor-positive surgical margins macroscopically were excluded. Prognostic factors such as age, gender, localization, admission status, compartment status, surgical margin, tumor size and adjuvant radiotherapy were evaluated. Results: Recurrence rate was 29%. Average disease free survival was 46 4 months. There was no statistically significant relation between prognostic factors and recurrence. Clinical results of the patients receiving adjuvant radiotherapy were more satisfactory. Conclusion: Adjuvant radiotherapy administration appears to be a rational treatment method instead of sacrificing function to achieve wide surgical margins.en10.3944/AOTT.2014.3171info:eu-repo/semantics/openAccessAdjuvant radiotherapylimb salvagerecurrencesurvivalArticle4815560WOS:00033519960001024643101Q2Q4